Publications by authors named "Ted Jacoby"

Claim this Profile
N
Novel Wound Care Practices in Bullous Pemphigoid: A Systematic Review.
Ted Jacoby, Danielle Yee, Ralina Karagenova, Joyce Chen, Roslyn Isseroff

Wound Repair Regen· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late-Onset Immune-Related Adverse Events After Immune Checkpoint Inhibitor Therapy.
Sienna M Durbin, Leyre Zubiri, Katherine Perlman, Chia-Yun Wu, Tristan Lim, Ted Victor Jacoby

JAMA Netw Open· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations between dermatologic immune-related adverse event morphologies and systemic immunomodulatory/immunosuppressive treatment: A large retrospective cohort study.
Rachel M Reardon, Katherine L Perlman, Maria S Asdourian, Nishi Shah, Ted V Jacoby

J Am Acad Dermatol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-grade cutaneous immune-related adverse events leading to immunotherapy discontinuation.
Ted V Jacoby, Maria S Asdourian, Nishi Shah, Tracey S Otto, Leah L Thompson

Clin Exp Dermatol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-infiltrating lymphocytes as a predictive biomarker of cutaneous immune-related adverse events after immune checkpoint blockade in patients with advanced melanoma.
Michael R Stephens, Maria S Asdourian, Ted V Jacoby, Nishi Shah, Leah L Thompson

J Am Acad Dermatol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noncutaneous immune-related adverse events predict overall and progression-free survival in patients with cutaneous toxicities after immune checkpoint inhibitor therapy.
Maria S Asdourian, Ted V Jacoby, Nishi Shah, Tracey Otto, Leah L Thompson

J Am Acad Dermatol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dermatology evaluation for cutaneous immune-related adverse events is associated with improved survival in cancer patients treated with checkpoint inhibition.
Ted V Jacoby, Nishi Shah, Maria S Asdourian, Leah L Thompson, Tracey S Otto

J Am Acad Dermatol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dercum's disease: A retrospective cohort study.
Maria S Asdourian, Nishi Shah, Ted V Jacoby, Janice Tiao, Flavia Fedeles

J Am Acad Dermatol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Morphologic characteristics of cutaneous immune-related adverse events in patients receiving immune checkpoint inhibitors combined with other anticancer therapies: A multicenter retrospective study.
Maria S Asdourian, Ted V Jacoby, Nishi Shah, Leah L Thompson, Tracey Otto

J Am Acad Dermatol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of multiple cutaneous immune-related adverse events among cancer patients after immune checkpoint blockade.
Maria S Asdourian, Nishi Shah, Ted V Jacoby, Yevgeniy R Semenov, Tracey Otto

J Am Acad Dermatol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating patterns of co-occurrence between cutaneous and noncutaneous immune-related adverse events after immune checkpoint inhibitor therapy.
Maria S Asdourian, Nishi Shah, Ted V Jacoby, Leah L Thompson, Tracey Otto

J Am Acad Dermatol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between serum lactate dehydrogenase and cutaneous immune-related adverse events among patients on immune checkpoint inhibitors for advanced melanoma.
Maria S Asdourian, Tracey S Otto, Ted V Jacoby, Nishi Shah, Leah L Thompson

J Am Acad Dermatol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of pre-existing drug allergies with cutaneous immune-related adverse events among patients on immune checkpoint inhibitor therapy.
Ted V Jacoby, Tracey S Otto, Maria S Asdourian, Nishi Shah, Mara Farcasanu

Br J Dermatol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Bullous Pemphigoid With Immune Checkpoint Inhibitor Therapy in Patients With Cancer: A Systematic Review.
Maria S Asdourian, Nishi Shah, Ted V Jacoby, Kerry L Reynolds, Steven T Chen

JAMA Dermatol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophilic Dermatosis and Management Strategies for the Inpatient Dermatologist.
Nishi Shah, Maria S Asdourian, Ted V Jacoby, Steven T Chen

Curr Dermatol Rep· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the treatment of cutaneous adverse events and adherence to National Comprehensive Cancer Network guidelines in patients receiving immune checkpoint inhibitors.
Michael S Chang, Ted V Jacoby, Tracey S Otto, Nishi Shah, Maria S Asdourian

Eur J Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asynchronous Teledermatology Assessment of Young Adult Acne Likely Concordant With In-Person Evaluation.
Ted Jacoby, Alice Woolard, Salim Chamoun, Ron Moy

J Drugs Dermatol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of bioidentical hormone replacement therapy in anti-aging medicine: a review of the literature.
Amanda Rosenthal, Ted Jacoby, Rachel Israilevich, Ronald Moy

Int J Dermatol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis